Menu Menu

GLUE    Monte Rosa Therapeutics Inc    1826457    
Income Statement
Revenue 9,216,000
Net Income -23,859,000
Profit Margin -258.89%

Balance Sheet
Current Assets 251,207,000
Assets 315,080,000
Current Liabilities 41,641,000
Liabilities 109,623,000
Equity 205,457,000
Shares Out 61,373,000

Cash Flow Statement
Operating Cash Flow -86,926,000
Investing Cash Flow -13,556,000

Market Analysis
Market Cap 357,543,809
Price 5.66
BVPS 3.35
PB 1.69
EPS -2.24
PS 9.70
FCF -100,482,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
3/14 2.19
Apr May Jun
5/09 -0.53
Jul Aug Sep
8/08 -0.43
Oct Nov Dec
11/07

Find a discrepancy? The most accurate way to find company fundamental data is to view GLUE documents filed with the SEC.


GLUE Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: